FOSUN HEALTH Logo

Menstrual Disorders & Dysmenorrhoea Treatment

catalogue

Menstrual Disorders & Dysmenorrhoea Treatment

Menstrual Disorders & Dysmenorrhoea Treatment

The options for a period problem are not arranged by strength, and the one that is right is decided by what the patient wants next rather than by how severe the symptom is. Someone planning a pregnancy, someone who needs the cycle to become predictable, and someone whose only request is that the pain should stop are three different situations that share a diagnosis and have different plans. Alongside that question sits the cause: where a cause has been found that can be treated, treating it is what changes the pattern, and where none has been found, the plan works on the symptom. The sections below set out the measures that act on pain, the hormonal options and what each is for, what happens when the cause is structural, and what the options that end the periods involve.

The question that decides between the options

The options fall into groups that differ in what they act on rather than in how strong they are:

  • Measures that act on the pain or the flow without changing the cycle. Anti-inflammatory drugs taken at the onset of the period, and tranexamic acid taken during the bleeding days, reduce what is felt and what is lost. Neither changes the cycle, and neither affects fertility.
  • Hormonal treatment, which makes the bleeding lighter and more predictable. Combined hormonal contraception, taken in the standard way or in extended cycles, and progestogens given by mouth, by injection, as an implant or through an intrauterine device. They act while they are being taken.
  • A hormone-releasing intrauterine device. One of the most effective measures for a heavy flow and for pain, and also a contraceptive, which is why it is a good option for some patients and the wrong one for others.
  • Treatment of a structural cause, where one has been found. Removal of a polyp, removal of fibroids, or treatment of the lining of the womb. This addresses the finding that produced the symptom rather than the symptom itself.

Why the question comes before the option. The same symptom gives three different plans depending on whether a pregnancy is being planned, whether the cycle needs to be predictable, or whether the aim is to stop the pain. The options also differ in what they rule out, which is why establishing what the patient wants next is the first step rather than a preliminary to it.

The measures that act on the pain, and the timing that matters

The non-hormonal measures are not a weaker version of the hormonal ones; they act on a different part of the mechanism:

  • Anti-inflammatory drugs reduce the prostaglandins that produce the cramping. They are the established first measure for period pain, and they work best when they are taken at the first sign of the period rather than once the pain is at its worst.
  • The timing is part of the treatment rather than a detail of it. Taken early, they prevent the prostaglandin surge that produces the cramp; taken at the peak, they are working against something that has already happened, which is why a treatment that failed in the past is worth reviewing for how it was taken.
  • Tranexamic acid reduces the flow rather than the pain. It is taken on the bleeding days only, it does not change the cycle, and it does not affect fertility, which makes it one of the few measures that can be used while a pregnancy is being attempted.
  • What has been tried before is worth recording properly. A treatment that did not work at a low dose, or that was taken only once the pain was established, has not been fairly tried, and knowing how it was used prevents an effective option from being written off.

Why the timing is the most common reason a good measure fails. Patients who report that painkillers do nothing often describe taking them after the pain has peaked. The difference between the two ways of taking the same drug is large enough that it changes the answer, and it is the first thing reviewed before the plan escalates.

The hormonal options, and what each one is for

Hormonal treatment is chosen for what it does to the cycle and the flow, and the options differ in what they contain and how they are delivered:

  • Combined hormonal contraception makes the bleeding lighter, shorter and predictable. Taken in the standard way or in extended cycles, it also reduces period pain for many patients. It acts while it is being taken, and the effect on the cycle reverses after it is stopped.
  • Progestogens act on the lining of the womb. Given by mouth, by injection, as an implant or through an intrauterine device, they thin the lining, which reduces both the flow and the pain.
  • A hormone-releasing intrauterine device is one of the most effective measures for a heavy flow. It delivers the progestogen where it is needed, it reduces the flow substantially for most patients, and it is also a contraceptive. It is fitted in a clinic and lasts for several years.
  • GnRH analogues are used for a defined period rather than indefinitely. They suppress the cycle, which is useful where a cause such as adenomyosis or endometriosis is producing the symptoms, and they are used to settle the pelvis before an operation where one is planned.
  • Hormonal treatment is not a way of avoiding a diagnosis. It is used after the pattern has been read and the treatable causes excluded, because it makes the bleeding lighter without explaining why it changed.

Two things patients are commonly told that are not true. Hormonal treatment does not accumulate in the body and does not need to be periodically cleared out; the effect wears off when it is stopped. And a withdrawal bleed on hormonal treatment is not a period in the sense of a cycle producing and shedding a lining on its own.

When a cause has been found, and it can be treated

Where the assessment has identified a structure producing the symptom, treating it is a different kind of step from suppressing the symptom:

  • A polyp is removed, and the flow often settles. Polyps are common, they are found on ultrasound, and removing one through the cervix addresses bleeding that the polyp was producing.
  • Fibroids are treated according to where they sit rather than how large they are. A fibroid that projects into the cavity of the womb disturbs the lining and the bleeding out of proportion to its size, and the options range from removing it to reducing the bleeding it causes by other means.
  • Adenomyosis is treated rather than removed. Because it is a change in the muscle of the womb itself, the measures are the ones that act on the lining and on the cycle, together with a device that delivers progestogen locally; removal of the womb is the option that ends it definitively.
  • Endometriosis is treated by suppressing it or by removing what is visible. The measures used for the pain are combined with hormonal suppression, and where an operation is planned the aim and what it is expected to achieve are stated before it rather than after it.

Why this group is placed after the symptom measures rather than before. A structural cause is not always the cause of the complaint, and imaging done before the pattern has been read tends to produce a finding that is then treated. Where the assessment has established that a structure explains the symptom, treating it is the most direct option available.

The options that end the periods, and the trade they make

Two options stop the bleeding altogether, and both end fertility, which is why they are considered deliberately rather than offered as a next step:

  • Endometrial ablation treats the lining of the womb. It reduces the flow substantially, and for some patients it stops the bleeding altogether. It is a procedure rather than an operation to remove an organ, and it is not appropriate for anyone who wants a future pregnancy.
  • Removal of the womb ends the bleeding and the period pain permanently. It is the option that removes the organ producing the symptom, and it also removes the possibility of a future pregnancy, which means it is chosen for a situation in which that is the right trade rather than as a step in a sequence.
  • Both are preceded by the question of whether everything else has had a fair trial. A measure that was taken at the wrong time, a hormonal option that was stopped for a reason that could have been managed, or a cause that was never looked for are all reasons to revisit the earlier options before this one.
  • Where the pain comes from elsewhere in the pelvis, removing the womb does not remove it. Endometriosis outside the womb and a condition of the pelvic floor produce pain that an operation on the womb does not address, which is why the source of the pain is established before the operation rather than after.

Why the trade is stated plainly rather than implied. Both options are effective at what they are intended to do, and both take something away that cannot be restored. The plan names what the option does, what it costs, and what the alternative is, and the decision belongs to the patient with that information in front of her.

The plan, the review, and what would change the approach

Whichever option is tried, what makes it a plan rather than a prescription is what surrounds it:

  • A defined period of trial, and a review date. A hormonal option is given long enough to show whether it works, and the review asks whether the symptom has changed by enough to matter rather than whether the medicine has been taken.
  • What would change the approach, written down in advance. The bleeding pattern that would prompt sampling the lining, the pain that would prompt looking for a cause, and the situation in which an option would be stopped are stated so that they are not re-decided under pressure later.
  • The iron deficit is followed until it is corrected. A blood count is repeated after treatment for the anaemia rather than assumed to have recovered, because the flow improving and the iron stores being replaced are two different things that take different amounts of time.
  • The records are prepared to travel, and they carry the pattern rather than just the results. A record that names what has been tried, at what dose and for how long, and what it produced, is what allows the next decision to be made anywhere without the earlier ones being repeated.
  • The plan says what is being treated and what is not. Where a structural finding is being watched rather than treated, and where a symptom is being managed rather than a cause removed, that is written down rather than left to be discovered at the next review.

What the plan does not promise. It does not promise that the cycle will return to a fixed interval, that the pain will disappear, or that a future pregnancy will follow. What it does is establish which part of the pattern has changed, whether a cause has been found, what the options are expected to do, and what would prompt a change of course.

Frequently Asked Questions

At what point should I consider an operation?

An operation is considered when there is something for it to do and when the alternatives have had a fair trial. The first kind of reason is a structural cause that has been identified and explains the symptom: a polyp producing a heavy flow, a fibroid projecting into the cavity of the womb, or a finding of the lining that needs to be sampled. The second is a symptom that remains substantial after the measures and the hormonal options have been tried properly. Where a finding does not explain the symptom, treating the finding is not the same as treating the problem, and the plan says so.

Do hormonal treatments affect future fertility?

They do not damage it. Combined hormonal contraception and progestogens prevent pregnancy while they are being taken, and the effect on the cycle reverses after they are stopped. A hormone-releasing intrauterine device works the same way and is removed when a pregnancy is wanted. Two things are genuinely irreversible: endometrial ablation and removal of the womb, neither of which is appropriate for someone who wants a future pregnancy. Separately, the condition that produced the symptom can have its own effect on fertility, which is one of the reasons a cause is looked for.

Is it safe to take a hormone-releasing intrauterine device if I have not had children?

Yes. Having had a pregnancy is not a requirement. There are specific situations where it is not suitable — a current pelvic infection, or a cavity of the womb distorted in a way that would not hold it — and those are established by the examination and the scan before it is fitted. Fitting is usually done in a clinic and can be uncomfortable, which is worth knowing before the appointment. What it offers in return is one of the most effective treatments for a heavy flow and for pain, together with several years of contraception.

What if I would rather not take anything at all?

That is a legitimate position, and what it changes is the plan rather than the assessment. The assessment still establishes which part of the pattern has changed and whether there is a cause that needs treating for reasons beyond the symptom. Where nothing is being taken, the things that remain are worth doing on their own: keeping the record, having the blood count and iron checked and the deficit corrected, and knowing which changes would prompt a review.

A plan built around what you want next, not around how severe the symptom looks.

The options act on different things, so the first question is whether a pregnancy is being planned, whether the cycle has to be predictable, or whether the aim is simply to stop the pain.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*